Here, we show that high levels of TFPI2 were statistically correlated with poor outcomes in UM individuals but better outcomes in CM individuals, which may be due to the few overlapping etiologies, mutation profiles, genetic signatures, and clinical behaviors of these two types of melanoma (59). Here, TFPI2 is linked to melanoma.